0001209191-11-059777.txt : 20111206 0001209191-11-059777.hdr.sgml : 20111206 20111206173103 ACCESSION NUMBER: 0001209191-11-059777 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111202 FILED AS OF DATE: 20111206 DATE AS OF CHANGE: 20111206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019611992 MAIL ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROCKFORD DAVID CENTRAL INDEX KEY: 0001050973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 111246559 MAIL ADDRESS: STREET 2: 509 MADISON AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-12-02 0 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0001050973 CROCKFORD DAVID C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 0 1 0 0 VP of Clinical & Reg. Affairs Stock Options (right to buy) 0.16 2011-12-02 4 A 0 91991 0.00 A 2018-12-02 Common Stock 91991 91991 D The shares underlying this option vest in full on December 31, 2011. /s/ Darren K. DeStefano, Attorney-in-Fact 2011-12-06